Panuramine

Panuramine (Wy-26,002) is an antidepressant which was synthesized in 1981 by Wyeth.[1] It acts as a potent and selective serotonin reuptake inhibitor (SSRI).[2] It was never marketed.[1]

Panuramine
Clinical data
ATC code
  • None
Identifiers
  • N-{[1-(naphthalen-2-ylmethyl)piperidin-4-yl]carbamoyl}benzamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H25N3O2
Molar mass387.483 g·mol−1
3D model (JSmol)
  • O=C(c1ccccc1)NC(=O)NC4CCN(Cc2ccc3c(c2)cccc3)CC4

See also

References
  1. David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
  2. Blurton PA, Broadhurst AM, Cross JA, Ennis C, Wood MD, Wyllie MG (September 1984). "Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat". Neuropharmacology. 23 (9): 1049–52. doi:10.1016/0028-3908(84)90127-8. PMID 6514142. S2CID 27269043.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.